10X Genomics Inc operates in the Biological products exc. diagnostic sector.
In addition to historical fundamental analyses, the complete report available to purchase compares 10X Genomics Inc with three other
companies in this sector in UNITED STATES :
sales of $366.26 million
of which 48%
was Product revenue - Filtration products),
Halozyme Therapeutics, Inc.
of which 33%
was Royalties), and
Denali Therapeutics Inc
of which 100%
was Biological Products).